イスラエルで最高の胃癌ステージ2医師 - トップ15名の医師

メリムスキー教授は、スーラスキー医療センターの軟部組織・骨腫瘍科を率い、胃癌の専門的な診療において数十年の経験を有しています。

• テルアビブ大学腫瘍学准教授
• パリのグスタフ・ルシー研究所にてフェローシップ研修修了
• ESMOサルコーマファカルティおよびASCO会員
• 癌治療成績に関する論文を多数発表

ペレス・シャロン医師は、スーラスキー医療センター（イチロフ）にて胃癌外科を専門とし、HIPEC（腹腔内温熱化学療法）や免疫療法などの先進的な治療に精通しています。

• 膵頭十二指腸切除術（ウィップル手術）を含む複雑な胃癌手術を実施
• 難治例に対する腹腔内温熱化学療法（HIPEC）を先駆的に導入
• 標的治療としてキイトルーダ（Keytruda）などの免疫療法を提供
• 腫瘍患者の臨床試験に対する意識に関する臨床研究を主導

Prof. Nadir Arber is a top gastroenterologist from Israel with over 30 years of experience in the field. He is specialized in the prevention, early diagnostics, and treatment of GI cancers, with education from Hebrew University, Tel Aviv University, and NewYork-Presbyterian Center. He has written over 300 papers on his research and is a member of numerous organizations in the field.

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

アリ・ラファエル教授――テルアビブ・スラスキー医療センター（イキロフ、テルアビブ）トランスレーショナル腫瘍学部門長および臨床がん研究部門研究員。患者一人ひとりのニーズに寄り添う個別対応のアプローチが高く評価されています。

資格および患者への貢献：

• 腫瘍科デイホスピタルを統括し、国家ゲノム医療プロジェクトを主導。最先端の研究へのアクセスを提供しています。

• 主任副研究者および主任研究者として、腫瘍内mRNA投与やウイルス製剤を含むフェーズI〜IIIの多数の臨床試験に携わってきました。患者は革新的な治療法への参加機会を得られます。

• 米国および英国における国際的な臨床経験を有し、世界水準の治療基準と先進的なプロトコルの適用を保証しています。

• 国際学術団体の会員（ESMO、IASLC、ISLB、ISCORT、Israeli Medical Association）。最新の治療基準を活用し、国際的な研究に参画しています。

• 　ICH GCP R2、Israeli MOH Guidelinesをはじめ、インフォームドコンセント、副作用管理および患者安全に関する最新課程を含む国際臨床実践基準に基づき、定期的に専門知識の更新および研修を実施しています。

ラファエル教授は、精密な治療レジメンの選択、革新的手法の導入、そして細やかな患者対応により高い信頼を得ており、治療のすべての段階において患者が安心して療養に臨める環境を提供しています。

ウルフ博士は、複雑ながん治療において高度な専門性を持つイスラエルの主要な教育病院、ソウラスキー医療センターの腫瘍内科部門を率いています。

• 腫瘍内科および内科を専門とする
• 国際患者のための英語に堪能
• ベングリオン大学の学位を取得
• 陸軍医療部隊において豊富な臨床経験を積む

Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.

Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.

Professional Profile

Dr. Almog Ben-Yaacov is a highly experienced surgeon specializing in general and oncological surgery. He graduated with honors from Semmelweis University Medical School in 2006. Following graduation, he completed two years of training in cardiac surgery, after which he continued with six additional years of advanced training in general surgery.

He currently serves as a senior surgeon at Sheba Medical Center. His clinical focus includes cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC), as well as the management of gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, Dr. Ben-Yaacov has performed over 200 HIPEC procedures.

Advanced Training

Dr. Ben-Yaacov has completed multiple specialized international training programs, including:

ESSO-certified HIPEC surgery course in Hamburg, Germany

Microwave liver ablation training in Reims, France

NanoKnife (irreversible electroporation) training at King’s College, London

In 2019, he further expanded his expertise through advanced surgical oncology training at Memorial Sloan Kettering Cancer Center, New York, USA.

Clinical Expertise & Procedures

Cytoreductive surgery with HIPEC

Resection of abdominal wall metastases

Minimally invasive and laparoscopic surgery

General and gastrointestinal surgery

Colorectal surgery

Laparoscopic cholecystectomy

Abdominal surgery

Surgical oncology

NanoKnife (irreversible electroporation)

Laparotomy

Current Position

Attending Surgeon, Department of General and Oncological Surgery (Surgery C)

Education & Surgical Training

MD (with honors), Semmelweis University Medical School, Hungary

Cardiothoracic Surgery Training, Sheba Medical Center

General Surgery Training, Montefiore Medical Center (Einstein Campus), New York, USA

General Surgery Training, Rabin Medical Center (Beilinson Campus), Israel

Board Certifications

General Surgery

Surgical Oncology

Selected Publications

Correlation Between Intraoperative and Pathological Findings in Patients Undergoing CRS and HIPEC

Berger Y, Jacoby H, Kaufmann MI, Ben-Yaacov A, et al.

Laparoscopic vs Open Hartmann’s Reversal: A Decade-Long Multicenter Retrospective Study

Horesh N, Lessing Y, Rudnicki Y, Ben-Yaacov A, et al.

Readmission Rates and Risk Factors Following CRS and HIPEC for Peritoneal Surface Malignancies

Dreznik Y, Hoffman A, Hamburger T, Ben-Yaacov A, et al.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Department:

Gastrointestinal Cancer Department

Specialties:

Internal Medicine, Medical Oncology, Cancer Epidemiology

Prof. Ben Boursi is a leading specialist in Internal Medicine, Medical Oncology, and Radiotherapy at Sheba Medical Center. He earned his medical degree with distinction (cum laude) from the School of Medicine at Tel Aviv University.

He completed his residency in Internal Medicine at Sourasky Medical Center in Tel Aviv, followed by advanced subspecialty training in Gastrointestinal Oncology and Cancer Epidemiology at the University of Pennsylvania, USA.

Academic and Research Appointments

Prof. Boursi holds an academic position within the Department of Epidemiology and Preventive Medicine at the School of Medicine, Tel Aviv University. In addition, he serves as an Associate Scholar at the Perelman School of Medicine, University of Pennsylvania.

Research and Scientific Contributions

Prof. Boursi’s research is centered on developing innovative therapeutic approaches in oncology, with a particular focus on the role of the microbiome in cancer development and treatment response.

He is internationally recognized as a leader in microbial modulation in cancer therapy and founded the ECOG-ACRIN Microbiome Working Group. His work has been published in leading scientific journals, including Science, and presented at major global oncology conferences, as well as featured in ASCO educational platforms and podcasts.

Alongside his research, Prof. Boursi is actively involved in academic teaching, delivering lectures on host–microbiome interactions at Tel Aviv University and Bar-Ilan University.

His research also extends to cancer prevention and early detection. He has developed predictive models for early diagnosis of colorectal and pancreatic cancers, which are currently undergoing clinical evaluation.

Clinical Expertise

Gastrointestinal oncology

Current Position

Physician, Gastrointestinal Cancer Department

Education and Training

B.Med.Sc (Summa cum laude), School of Medicine, Tel Aviv University

MD (Magna cum laude), School of Medicine, Tel Aviv University

Clinical and Research Fellowship in Gastrointestinal Oncology and Cancer Epidemiology, Perelman School of Medicine, University of Pennsylvania

Elective Training in Medical Oncology, MD Anderson Cancer Center

Elective Training in Medical Oncology, Mayo Clinic

Advanced Research Training, Weizmann Institute of Science

Board Certifications

Internal Medicine

Medical Oncology

Professional Memberships

Israeli Association of Clinical Oncology and Radiotherapy (ISCORT)

American Society for Cancer Research

Selected Publications

Immune-related adverse events as predictors of durable response to BRAF inhibitors in metastatic melanoma with BRAF V600 mutation

Ben-Betzalel G, Baruch EN, Boursi B, et al.

Re-evaluating the IDEA classification: Novel predictive and prognostic markers in stage III colon cancer

Margalit O, Mamtani R, Yang YX, Boursi B, et al.

Prognostic significance of carcinoembryonic antigen (CEA) levels in stage I–II colon cancer

Margalit O, Mamtani R, Yang YX, Boursi B, et al

Dr. Alexander Beny is a Oncologist at the Rambam Medical Center who is Board Certified in Oncology and speaks English and Hebrew. He has extensive experience and education in the field and is available for contact at the hospital.

Dr. Tamar Jablonski-Perec is an oncologist at Hadassah Medical Center in Jerusalem. She holds a Doctor of Medical Sciences from the Hebrew University and has experience from the renowned Sloan-Kettering Cancer Center in New York. She is the Head of Institute of Oncology, Head of Breast Cancer Treatment Center, and Professor of the Department of Oncology at the Hebrew University. She is a member of several international cancer communities and was awarded a scholarship from the Hadassah Medical School.